Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer

NCT07570524 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT07570524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer
Lead sponsor
Center Eugene Marquis
Phase
Observational
Overall status
Recruiting
Start date
June 25, 2026
Completion date
June 25, 2036
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple-negative breast cancer (tnbc)